Skip to main content

Table 3 Genotype frequencies of CTLA4 + 49A/G and IL4 -590C/T polymorphism in HCV induced HCC patients and Control groups

From: Association of CTLA-4 and IL-4 polymorphisms in viral induced liver cancer

Gene

Genetype

Patient (n = 213)

Control (n = 216

Odds ratio

95% CI –odds ratio

Relative risk

95% CI—relative risk

P value

n, (%)

n, (%)

CTLA4

 AG

134 (62.9%)

55 (25.5%)

4.96

3.29 -7.52

2.154

1.76—2.64

 < 0.0001

 GG

79 (37.1%)

161 (74.5%)

0.20

0.13—0.30

0.4643

0.37—0.56

 < 0.0001

IL4

 CC

138 (64.8%)

60 (27.8%)

4.78

3.19 -7.17

2.14

1.75—2.65

 < 0.0001

 CT

46 (21.6%)

136 (62.9%)

0.16

0.11—0.25

0.37

0.28—0.48

 < 0.0001

 TT

29 (13.6%)

20 (9.3%)

1.54

0.84—2.84

1.22

0.91—1.53

0.17